The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

CA16020715

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 3e11f683-5644-4adc-bee9-7e4513f592af

HGVS expressions

NM_000277.1:c.30dup
NC_000012.12:g.102917101dup
CM000674.2:g.102917101dup
NC_000012.11:g.103310879dup
CM000674.1:g.103310879dup
NC_000012.10:g.101835009dup
NG_008690.1:g.5502dup
NG_008690.2:g.46310dup
NM_000277.2:c.30dup
NM_001354304.1:c.30dup
NM_000277.3:c.30dup
ENST00000307000.7:c.-118dup
ENST00000546844.1:c.30dup
ENST00000547319.1:n.341dup
ENST00000549111.5:n.126dup
ENST00000550978.6:n.14dup
ENST00000551337.5:c.30dup
ENST00000551988.5:n.119dup
ENST00000553106.5:c.30dup
ENST00000635500.1:n.29-4203dup

Pathogenic

Met criteria codes 4
PM3_Supporting PP4_Moderate PM2 PVS1

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The PAH: c.30_31insC variant is a frameshift variant occurring in exon 1 of 13 in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1). The variant has been previously reported with the known pathogenic p.R243Q allele (PM3-supporting, no parental analysis reported) in 1 Chinese case with classic PKU (PMID: 26322415), as assessed by plasma Phe levels; BH4 deficiency was excluded by analysis of urinary pterins and dihydropteridine reductase activity in erythrocytes (PP4_Moderate). It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2).
Met criteria codes
PM3_Supporting
The variant has been previously reported in trans with the known pathogenic p.R243Q allele (PM3) in 1 Chinese case with classic PKU (PMID: 26322415). Parental testing not reported.

PP4_Moderate
The variant has been previously reported in trans with the known pathogenic p.R243Q allele (PM3) in 1 Chinese case with classic PKU (PMID: 26322415), as assessed by plasma Phe levels; BH4 deficiency was excluded by analysis of urinary pterins and dihydropteridine reductase activity in erythrocytes (PP4_Moderate). It is also noted as occurring in 1 Chinese PKU case, without further information and/or patient identifier, in another publication (PMID: 26503515) including the same authors as in the other publication, published in the same year. Thus conservatively, counted as occurring in 1 proband.

PM2
It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2).
PVS1
The PAH: c.30_31insC variant is a frameshift variant occurring in exon 1 of 13 in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1).
Approved on: 2019-08-11
Published on: 2019-08-11
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.